Chronic hepatitis c

Roche

Company1 trialPhase 4155 people

Tanabe Pharma Corporation

Company1 trialPhase 3596 people

Antipodean Pharmaceuticals

Company1 trialPhase 230 people

Transgene

Company1 trialPhase 142 people

University of Turin, Italy

1 trialPhase 4200 people

Valme University Hospital

1 trialPhase 4126 people

National Institute of Diabetes and Digestive and Kidney Diseases

1 trialPhase 4121 people

Federal University of São Paulo

1 trialPhase 485 people